This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Over the past four years, this core has been instrumental to our recovery following Hurricane Katrina. Focusing on mentoring and career development, the Faculty Development Core explores novel concepts, approaches, and methods and brings objectivity, planning, accountability, and scholarship to faculty development. Activities are designed to meet the specific needs of the PJIs, most of whom are non-native English speakers. Components of this core include an ongoing faculty development curriculum that instills research, administration, communication, education, and leadership, and cultural competence. This core provides a structured pathway that assists mentors and mentees with designing, monitoring, and evaluating mentoring contracts and provides research seminars, Work in Progress meetings, journal clubs, and workshops on grantsmanship, effective communication skills, and the ethical conduct of research. In addition, the core designs and evaluates mentoring activities at different levels: peer review, scientific, career, and external. For each PJI, the core prepares a career development plan that includes specific targets, measurable outcomes, and periodic evaluation. The faculty development program has become a model at LSUHSC and for other COBRE programs in IDeA states.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-CR-B (01))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Louisiana State Univ Hsc New Orleans
Internal Medicine/Medicine
Schools of Medicine
New Orleans
United States
Zip Code
Sanchez, Maria Dulfary; Ochoa, Augusto C; Foster, Timothy P (2016) Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways. Antiviral Res 132:13-25
Dai, Lu; Bai, Lihua; Lin, Zhen et al. (2016) Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus. Oncotarget 7:47052-47060
Schieffelin, John; Moses, Lina M; Shaffer, Jeffrey et al. (2016) Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation. Clin Trials 13:66-72
Dai, Lu; Trillo-Tinoco, Jimena; Cao, Yueyu et al. (2015) Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma. Blood 126:2821-31
Dai, Lu; Chen, Yihan; Bonstaff, Karlie et al. (2015) Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients. Cancer Lett 362:158-66
Dai, Lu; Trillo-Tinoco, Jimena; Bai, Aiping et al. (2015) Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression. Oncotarget 6:24246-60
Geng, Degui; Kaczanowska, Sabina; Tsai, Alexander et al. (2015) TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity. Cancer Res 75:1959-71
Fletcher, Matthew; Ramirez, Maria E; Sierra, Rosa A et al. (2015) l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells. Cancer Res 75:275-83
Qin, Zhiqiang; Peruzzi, Francesca; Reiss, Krzysztof et al. (2014) Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis. Viruses 6:4571-80
Sierra, Rosa A; Thevenot, Paul; Raber, Patrick L et al. (2014) Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer. Cancer Immunol Res 2:800-11

Showing the most recent 10 out of 81 publications